SYMPOSIUM 1: IEPA Symposium: Intervention strategies for supporting people in the early stages of psychosis
(Organised by IEPA)

Kate Hardy: Current state of the evidence for CBT for psychosis
Juliana Onwumere: Evidence for providing families and carers with support during the early phase of psychosis
Marieke Begemann: Antipsychotic medication discontinuation and dose reduction - HAMLETT Trial

SYMPOSIUM 2: Early diagnosis of younger onset dementia in people with psychiatric presentations
Chairpersons: Dionisios Velakoulis (Australia) - Yolande Pijnenberg (The Netherlands)

Yolande Pijnenberg (The Netherlands): Differentiating FTD from psychiatric presentations
Alexander Santillo (Sweden): Current status of biomarkers in younger onset dementia
Dhamidhu Eratne (Australia): The role of neurofilament light levels in the neuropsychiatry clinic

SYMPOSIUM 3: Early onset mood disorders: under-recognised and under-treated?

Allan Young (United Kingdom): Slow train coming: The onset of Bipolar Disorder
Jeniffer Dwyer (USA): Management of Pediatric Treatment-Resistant Depression: Advances and Challenges
Chris Davey (Australia): Early intervention for depression: Covering the spectrum of severity and complexity

SYMPOSIUM 4: Discrete versus Continuum Models of Schizophrenia and Psychosis: Current Status and Future Directions
Chairpersons: Jai Shah (Canada) - Sinan Gülöksüz (The Netherlands)

Laila Hasmi (The Netherlands): Can we really separate non-psychotic disorders from the Clinical High Risk for Psychosis phenotype?
Jai Shah (Canada): Timing, Distribution, and Relationship between Nonpsychotic and Subthreshold Psychotic Symptoms Prior to Emergence of a First Episode of Psychosis
Andrea Raballo (Italy): Between Utility and Descriptive density: A Clinical-Phenomenological Stance on the Discrete versus Continuum Models Debate

SYMPOSIUM 5: Prevention and early detection of psychosis: where are we now?
Chairpersons: Olga Karpenko (Russia) - David Baron (United States)

David Baron (United States): The role of primary care in identifying psychosis
Paolo Fusar-Poli (United Kingdom): Primary prevention of psychosis: achievements and challenges
Olga Karpenko (Russia): Secondary prevention in first episode psychosis

SYMPOSIUM 6: Stress and the continuum of disease development: A transdiagnostic target for primary, secondary and tertiary prevention
Chairpersons: George Chrousos (Greece) – Panagiota Pervanidou (Greece)

George Chrousos (Greece): The origins of Stress: Philosophical and historical concepts
Panagiota Pervanidou (Greece): Early life stress and its impact on childhood, adolescence and adulthood
Agorastos Agorastos (Greece): Stress System physiology and pathophysiology in disease development

SYMPOSIUM 7: Psychoses in the Global South
Chairpersons: Craig Morgan (United Kingdom) - Oye Gureje (Nigeria)

Thara Rangaswamy (India): INTREPID II: International Programme of Research on Psychoses in Diverse Settings
Tessa Roberts (United Kingdom): Neighbourhoods and recovery from psychosis: Perspectives from Trinidad
Bonga Chiliza (South Africa): PsyMap-ZN: Psychosis Mapping Project in KwaZulu-Natal, South Africa
Charlotte Hanlon (United Kingdom/Ethiopia): SCOPE: Studying the Contexts of recent Onset Psychoses in Ethiopia to develop interventions to improve outcomes

SYMPOSIUM 8: Early detection and intervention in psychosis and clinical high risk states
Chairpersons: Melissa Weibell (Norway) - Jan Olav Johannessen (Norway)

Inge Joa & Jone Bjørnestad (Norway): Early detection and intervention in Clinical High Risk for psychosis and symptom-level predictors of course
Petros Drosos (Norway): One-Year Outcome and Adherence to Pharmacological Guidelines in First-Episode Schizophrenia
Wenche ten Velden Hegelstad (Norway): Dynamics of Duration of Untreated Psychosis in a widening mental health care environment

SYMPOSIUM 9: Novel evidence-based approaches to dementia prevention

Dimitris N Kiosses (USA): Emotion regulation  and problem-solving approaches to improve  mood, functioning, and cognition in older adults  with depression and cognitive deficits
Laura Baker (USA): (the title of the presentation will be announced soon)
Nikos Scarmeas (Greece): Mediterranean diet and cognition: epidemiology and mechanisms
Miia Kivipelto (Finland): Multidomain interventions for prevention and risk reduction of dementia: From FINGER to World-Wide FINGERS

SYMPOSIUM 10: Neurodevelopmental disorders: Early detection and intervention in vulnerable groups, from the antenatal period to childhood and adult life
Chairpersons: Covadonga Martinez Diaz-Caneja (Spain)

Laura Pina-Camacho (Spain): The PremTEA Project. Early detection of neurodevelopmental disorders in extremely preterm newborns: a four year follow-up study
Farah Ghosn: The Peristress Project. Early detection of neurodevelopmental disorders in babies born after a threatened preterm labor. From the antenatal period to early childhood
Mireia Solerdelcoll (United Kingdom): The ePrime Study. Early detection of neurodevelopmental disorders and phenotyping of the brain in very preterm newborns: from birth to young adult life

SYMPOSIUM 11: Decreasing or stopping antipsychotics: a neglected topic?

David Taylor (United Kingdom): Long-acting antipsychotic injections and treatment cessation
Merete Nordentoft (Denmark): How to identify the group of patients with schizophrenia who can manage without long term medication?
Stefan Leucht (Germany): Too low antipsychotic dose as a risk factor for a poor course of schizophrenia?

SYMPOSIUM 12: Hearing and vision support as a means of early intervention for older adults with memory impairment
Chairpersons: Leroi Iracema (Ireland) - Antonis Politis (Greece)

Antonis Politis (Greece): Hearing and vision deficits associated behavioural and psychiatric disturbances in dementia: An opportunity for early intervention to avoid drug therapy?
Chryssoula Thodi & Anna Palvina Charalambous (Cyprus): Developing a resource and knowledge toolkit to support professionals in early sensory interventions for older adults with cognitive impairment
Piers Dawes (Australia/United Kingdom): Intervening early with hearing and vison support to improve outcomes for people with cognitive impairment

SYMPOSIUM 13: How do environmental and genetic risk factors shape the vulnerability for psychotic disorders?

Marta Di Forti (United Kingdom): Cannabis-associated psychosis: Is it worth modifying the environment if genes have such an important role? 
Sinan Gülöksüz (The Netherlands): The exposome of psychosis
Vangelis Vassos (United Kingdom): Combining genes and environment for risk prediction in psychiatry: progress and challenges

SYMPOSIUM 14: Ethics and personal meaning in patients with early onset psychosis

Ilina Singh (United Kingdom): Valued Outcomes and Identified Drivers of Change among Participants in the England Early Intervention in Psychosis Programme
Rosa Ritunnano (United Kingdom): Understanding delusional complexities in early psychosis: why meanings matter
Mathew Broome (United Kingdom): Μeaning in phenomenological psychopathology: the case of psychosis

SYMPOSIUM 15: Early intervention in neurodiverse children and adolescents
Chairpersons: Marinos Kyriakopoulos (Greece/United Kingdom) - Angela Hassiotis (United Kingdom)

Hassiotis Angela (United Kingdom): Evaluation of Parent Intervention for Challenging Behaviour in preschool children with severe intellectual disabilities (EPICC-ID): a randomised controlled trial
Konstantina Magklara (Greece): Specific developmental disorders: Early detection and intervention for children under 5 years in a community mental health centre in Greece 
Dominic Wrein (United Kingdom) & Marinos Kyriakopoulos (Greece/United Kingdom): The Autism and Intellectual Disability Intensive Intervention Team (AID-ITT): A novel approach to intensive intervention for adolescents at risk of inpatient admission

SYMPOSIUM 16: ADHD: life-time continuity, serious mental illness, and genetics

Luis Augusto Rohde (Brazil): What is new on ADHD trajectories? From new patterns to prediction
Tobias Banaschewski (Germany): ADHD – neurobiological findings and their implications
Anita Thapar (United Kingdom): Recent research findings on young adult ADHD

SYMPOSIUM 17: Electrophysiological biomarkers and early intervention in neuropsychiatric disorders across the lifespan
(Organised by: WPA Section on Psychoneurobiology)
Chairpersons: Armida Mucci (Italy) - Canan Basar-Eroglu (Turkey)

Bahar Güntekin (Turkey): Electrophysiological biomarkers of cognitive impairment in patients with Alzheimer disease: possible use in clinical trial
Armida Mucci (Italy): Electrophysiological biomarkers of functional impairment in schizophrenia, implication for early intervention
Canan Basar-Eroglu (Turkey): Altered oscillations and core symptoms of psychosis

SYMPOSIUM 18: Early Intervention in Psychosis: From promise to delivery and beyond

Silvana Galderisi (Italy): Negative symptoms in first-episode schizophrenia and in children/adolescents at ultra-high risk for psychosis
Paolo Fusar-Poli (United Kingdom): Preventing psychosis: achievements and challenges
Merete Nordentoft (Denmark): How results of clinical
trials can be implemented in clinical practice

SYMPOSIUM 19: Early intervention in bipolar disorders: problems and potential solutions
(WPA Section of Affective Disorders)
Chairpersons: Elizabeth Scott (Australia) - Jan Scott (United Kingdom)

Jan Scott (United Kingdom): Conceptualising and estimating duration of untreated bipolar disorders: a systematic review and meta-analysis of data from around the world
Kathleen Merikangas (USA): Opportunities for prevention of mood disorders
Ian Hickie (Australia): Early intervention: right care right time